Annual CAPEX
$9.28 M
-$3.95 M-29.84%
31 December 2023
Summary:
Verve Therapeutics annual capital expenditures is currently $9.28 million, with the most recent change of -$3.95 million (-29.84%) on 31 December 2023. VERV annual CAPEX is now -29.84% below its all-time high of $13.23 million, reached on 31 December 2022.VERV CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$936.00 K
-$44.00 K-4.49%
30 September 2024
Summary:
Verve Therapeutics quarterly capital expenditures is currently $936.00 thousand, with the most recent change of -$44.00 thousand (-4.49%) on 30 September 2024. Over the past year, it has dropped by -$125.00 thousand (-11.78%). VERV quarterly CAPEX is now -81.16% below its all-time high of $4.97 million, reached on 31 December 2022.VERV Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$4.53 M
-$125.00 K-2.68%
30 September 2024
Summary:
Verve Therapeutics TTM capital expenditures is currently $4.53 million, with the most recent change of -$125.00 thousand (-2.68%) on 30 September 2024. Over the past year, it has dropped by -$7.53 million (-62.42%). VERV TTM CAPEX is now -66.76% below its all-time high of $13.64 million, reached on 30 June 2023.VERV TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.8% | -11.8% | -62.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
VERV CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -29.8% | at low | -81.2% | +116.2% | -66.8% | +71.9% |
| 5 y | 5 years | -29.8% | at low | -81.2% | +116.2% | -66.8% | +71.9% |
| alltime | all time | -29.8% | at low | -81.2% | +116.2% | -66.8% | +71.9% |
Verve Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $936.00 K(-4.5%) | $4.53 M(-2.7%) |
| June 2024 | - | $980.00 K(+126.3%) | $4.66 M(-26.5%) |
| Mar 2024 | - | $433.00 K(-80.2%) | $6.34 M(-31.7%) |
| Dec 2023 | $9.28 M | $2.19 M(+105.9%) | $9.28 M(-23.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $1.06 M(-60.1%) | $12.07 M(-11.6%) |
| June 2023 | - | $2.66 M(-21.1%) | $13.64 M(+24.2%) |
| Mar 2023 | - | $3.38 M(-32.1%) | $10.98 M(+44.4%) |
| Dec 2022 | $13.23 M | $4.97 M(+88.4%) | $7.61 M(+188.4%) |
| Sept 2022 | - | $2.64 M | $2.64 M |
FAQ
- What is Verve Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Verve Therapeutics?
- What is Verve Therapeutics annual CAPEX year-on-year change?
- What is Verve Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Verve Therapeutics?
- What is Verve Therapeutics quarterly CAPEX year-on-year change?
- What is Verve Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Verve Therapeutics?
- What is Verve Therapeutics TTM CAPEX year-on-year change?
What is Verve Therapeutics annual capital expenditures?
The current annual CAPEX of VERV is $9.28 M
What is the all time high annual CAPEX for Verve Therapeutics?
Verve Therapeutics all-time high annual capital expenditures is $13.23 M
What is Verve Therapeutics annual CAPEX year-on-year change?
Over the past year, VERV annual capital expenditures has changed by -$3.95 M (-29.84%)
What is Verve Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of VERV is $936.00 K
What is the all time high quarterly CAPEX for Verve Therapeutics?
Verve Therapeutics all-time high quarterly capital expenditures is $4.97 M
What is Verve Therapeutics quarterly CAPEX year-on-year change?
Over the past year, VERV quarterly capital expenditures has changed by -$125.00 K (-11.78%)
What is Verve Therapeutics TTM capital expenditures?
The current TTM CAPEX of VERV is $4.53 M
What is the all time high TTM CAPEX for Verve Therapeutics?
Verve Therapeutics all-time high TTM capital expenditures is $13.64 M
What is Verve Therapeutics TTM CAPEX year-on-year change?
Over the past year, VERV TTM capital expenditures has changed by -$7.53 M (-62.42%)